Delisting of Securities of Northern Revival Acquisition Corporation; Veradigm Inc.; Neptune Wellness Solutions Inc.; Panbela Therapeutics, Inc.; Bit Brother Limited; Nocturne Acquisition Corporation; View, Inc.; Casa Systems, Inc.; Gamida Cell Ltd.; Eiger BioPharmaceuticals, Inc.; Acorda Therapeutics, Inc.; Motus GI Holdings, Inc.; ProSomnus, Inc.; and Mobile Global Esports Inc. from The Nasdaq Stock Market
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares, unit, and warrants of Northern Revival Acquisition Corporation. Northern Revival Acquisition Corporation’s securities were suspended on February 15, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Veradigm Inc. Veradigm Inc.’s securities were suspended on February 29, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the ordinary shares of Neptune Wellness Solutions Inc. Neptune Wellness Solutions Inc.’s securities were suspended on March 7, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Panbela Therapeutics, Inc. Panbela Therapeutics, Inc.’s securities were suspended on March 7, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Bit Brother Limited. Bit Brother Limited’s securities were suspended on March 7, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the ordinary shares, rights, and units of Nocturne Acquisition Corporation. Nocturne Acquisition Corporation’s securities were suspended on April 4, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the Class A common stock and warrants of View, Inc. View, Inc.’s securities were suspended on April 5, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Casa Systems, Inc. Casa Systems, Inc.’s securities were suspended on April 5, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the ordinary shares of Gamida Cell Ltd. Gamida Cell Ltd.’s securities were suspended on April 8, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.’s securities were suspended on April 11, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Acorda Therapeutics, Inc. Acorda Therapeutics, Inc.’s securities were suspended on April 12, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Motus GI Holdings, Inc. Motus GI Holdings, Inc.’s securities were suspended on April 16, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock and warrant of ProSomnus, Inc. ProSomnus, Inc.’s securities were suspended on April 18, 2024, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Mobile Global Esports Inc. Mobile Global Esports Inc.’s securities were suspended on April 18, 2024, and have not traded on Nasdaq since that time.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy